Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 756

Similar articles for PubMed (Select 18483329)


Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.

Quick SK, Shields PG, Nie J, Platek ME, McCann SE, Hutson AD, Trevisan M, Vito D, Modali R, Lehman TA, Seddon M, Edge SB, Marian C, Muti P, Freudenheim JL.

Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1082-7. doi: 10.1158/1055-9965.EPI-07-2755.


A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.

Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1462-7.


Oxidative stress-related genotypes, fruit and vegetable consumption and breast cancer risk.

Li Y, Ambrosone CB, McCullough MJ, Ahn J, Stevens VL, Thun MJ, Hong CC.

Carcinogenesis. 2009 May;30(5):777-84. doi: 10.1093/carcin/bgp053. Epub 2009 Mar 2.


Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk.

Ahn J, Gammon MD, Santella RM, Gaudet MM, Britton JA, Teitelbaum SL, Terry MB, Neugut AI, Josephy PD, Ambrosone CB.

Cancer Res. 2004 Oct 15;64(20):7634-9.


Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.

Zhang L, Gu L, Qian B, Hao X, Zhang W, Wei Q, Chen K.

Breast Cancer Res Treat. 2009 Mar;114(2):327-38. doi: 10.1007/s10549-008-9998-0. Epub 2008 Jul 16.


Lifetime adult weight gain, central adiposity, and the risk of pre- and postmenopausal breast cancer in the Western New York exposures and breast cancer study.

Han D, Nie J, Bonner MR, McCann SE, Muti P, Trevisan M, Ramirez-Marrero FA, Vito D, Freudenheim JL.

Int J Cancer. 2006 Dec 15;119(12):2931-7.


A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.

Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.

Breast Cancer Res Treat. 2007 Jan;101(1):73-81. Epub 2006 Jun 29. Erratum in: Breast Cancer Res Treat. 2007 Apr;102(2):249.


Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.

MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk.

Breast Cancer Res Treat. 2010 Jan;119(2):463-74. doi: 10.1007/s10549-009-0407-0. Epub 2009 May 8. Erratum in: Breast Cancer Res Treat. 2010 Jan;119(2):475.


Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.

Cui Y, Shu XO, Cai Q, Jin F, Cheng JR, Cai H, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1096-101.


The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.

Hirose K, Matsuo K, Toyama T, Iwata H, Hamajima N, Tajima K.

Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1407-11.


Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk.

Mitrunen K, Kataja V, Eskelinen M, Kosma VM, Kang D, Benhamou S, Vainio H, Uusitupa M, Hirvonen A.

Pharmacogenetics. 2002 Jan;12(1):67-72.


The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.

Haiman CA, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Speizer FE, Kelsey KT, Hunter DJ.

Cancer Res. 1999 Mar 1;59(5):1015-20.


MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study.

Le Marchand L, Haiman CA, Wilkens LR, Kolonel LN, Henderson BE.

Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2071-7.


Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk.

Moysich KB, Shields PG, Freudenheim JL, Schisterman EF, Vena JE, Kostyniak P, Greizerstein H, Marshall JR, Graham S, Ambrosone CB.

Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):41-4.


CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.

Han S, Lee KM, Choi JY, Park SK, Lee JY, Lee JE, Noh DY, Ahn SH, Han W, Kim DH, Hong YC, Ha E, Yoo KY, Kang D.

Breast Cancer Res Treat. 2008 Jul;110(2):387-93. Epub 2007 Oct 17.


Association of cyclin D1 genotype with breast cancer risk and survival.

Shu XO, Moore DB, Cai Q, Cheng J, Wen W, Pierce L, Cai H, Gao YT, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):91-7.


Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer.

Yim DS, Parkb SK, Yoo KY, Yoon KS, Chung HH, Kang HL, Ahn SH, Noh DY, Choe KJ, Jang IJ, Shin SG, Strickland PT, Hirvonen A, Kang D.

Pharmacogenetics. 2001 Jun;11(4):279-86.


Risk factors for hormone receptor-defined breast cancer in postmenopausal women.

Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8.


Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.

Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H, Wirfält E.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1101-10. doi: 10.1158/1055-9965.EPI-08-0401. Epub 2009 Mar 31.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk